Although advanced imaging exams have proven benefits in defining disease severity, new data indicate that more sophisticated studies might not impact outcomes as much as previously thought. 

Redundant brain pathways can serve as pre-symptomatic indicators of mild cognitive impairment (MCI) in aging individuals, allowing care teams to design first-line neuropsychological exercises for slowing the possible approach of Alzheimer’s disease.

Both vaccine status and variant type were shown to be associated with differing COVID severity and chest CT patterns. 

The administration also is strengthening its ability to oversee imaging providers and enforce standards in the Mammography Quality Standards Act. 

Axillary lymphadenopathy following COVID vaccination and/or boosters is a finding all radiologists must be mindful of when interpreting imaging, but new data clarify the timeline for when the side effect should resolve.

A new paper published in Clinical Imaging details the impact of a high-resolution CT reporting template catered specifically to interstitial lung disease.

The tool’s sensitivity was recorded as 99.1% for abnormal radiographs and 99.8% for critical radiographs—better than two board-certified radiologists who also interpreted the exams. 

The risk stratification system was put to the test in more than 3,000 cases and proved itself to be a beneficial tool in predicting future AVM rupture across multiple risk groups.